On June 19, 2018, the seminar “Innovation Leading – Vitamin K2 International Industry Development Dynamics” was held in Xijiao Hotel, Shanghai. More than 200 business leaders and senior executives from the international functional health food and pharmaceutical industry attended the conference.Chairman of the Chinese Nutrition Society Yang Yuexin said: “At present, China's vitamin K2 industry is still in the initial stage of development.I hope that more scientific and technological workers will help the development of China's vitamin K2 industry. ”President Zhang Hejun of China Pharmaceutical Quality Management Association hopes that SungenBio, as the leader of China's vitamin K2 industry, will drive more Chinese enterprises to jointly promote the innovative development of vitamin K2.

The international vitamin K2 research authoritative expert analyzed the safety of natural vitamin K2 (MK-7) and its significant effects on enhancing bone mineral density, reducing fracture risk and relieving developmental bone pain. Li Shuzhuang, Professor of Dalian Medical University, analyzed the protective effect of vitamin K2 micronutrient added to traditional calcium on blood vessels and heart. Professor Zhang Fengjiao of Shenyang Pharmaceutical University analyzed that vitamin K2 promotes the combination of calcium and collagen to achieve the mechanism of getting calcium into bone.Professor Deng Yihui of Shenyang Pharmaceutical University analyzed the latest research on the anticancer effect of vitamin K2 on blood vessels and organs. Dr. Tan Jing of North Sichuan Medical College found that long-term compensation of vitamin K2 in dialysis patients can effectively improve vascular calcification.

As the only manufacturer and product solution provider in China to produce all-trans natural vitamin K2 (MK-7),SungenBio will establish in-depth cooperation with more scientific research institutions and enterprises, leading the vitamin K2 industry in China to move towards new development.